Skip to main content
Equibles

UBS Group AG

Position in TOVX — Theriva Biologics, Inc.

CIK 1610520 ZURICH, V8
Back to TOVX Full portfolio

Position in TOVX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,262
-$29,862 QoQ
Shares Held
61,053
-72.9% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 24 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TOVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. TOVX ranks #436 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in TOVX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,262 61,053
2026-03-31 $45,124 225,624
2025-12-31 $40,195 191,410
2025-09-30 $9,393 22,913
2025-06-30 $0 1
2025-03-31 $8,635 7,851
2024-12-31 $28,710 16,406
2024-09-30 $24,634 17,851
2024-06-30 $1 3
2024-03-31 $1 3
2023-12-31 $1 3
2023-06-30 $5,933 5,933
2022-12-31 $2,256 5,015
2022-09-30 $6,698 6,766